Healthcare
Vantis Vascular
Recorded December 11, 2025
Vantis Vascular is developing breakthrough tools to deliver game-changing outcomes in advanced vascular intervention
Vantis Vascular is developing breakthrough tools to deliver game-changing outcomes in advanced vascular intervention
Regenxbio [NASDAQ: RGNX] has three assets in pivotal trials with the potential to become standard of care in markets worth a total of $26B.
NextTrip (NASDAQ: NTRP) is a travel discovery and booking platform built to disrupt an industry that’s been stagnant for 30 years
NextTrip (NASDAQ: NTRP) is a travel discovery and booking platform built to disrupt an industry that’s been stagnant for 30 years
Scout Discoveries is a vertically integrated exploration company that is ready to meet the demand for domestically sourced critical minerals
Scout Discoveries is a vertically integrated exploration company that is ready to meet the demand for domestically sourced critical minerals
5E Advanced Materials (NASDAQ: FEAM) produces boron to support national security, energy transition, and agricultural resilience in the U.S.
5E Advanced Materials (NASDAQ: FEAM) produces boron to support national security, energy transition, and agricultural resilience in the U.S.
NextTrip (NASDAQ: NTRP) is an innovative travel discovery and booking platform built to disrupt an industry that’s been stagnant for the past 30 years
NextTrip (NASDAQ: NTRP) is an innovative travel discovery and booking platform built to disrupt an industry that’s been stagnant for the past 30 years
Gene therapy stands at the forefront of medical innovation, offering the potential to not only treat but also cure a wide range of genetic disorders.
Vast Therapeutics is pioneering a transformational approach to treating chronic and life-threatening respiratory infections including cystic fibrosis